Back
VanEck Rare Earth & Strat Mtls ETF Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
36
REMX
VanEck Rare Earth & Strat Mtls ETF
Last Price:
42.57
Seasonality Move:
-1.17%
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
242.97
Seasonality Move:
20.36%
Sell
36
VanEck Rare Earth & Strat Mtls ETF (REMX)
is a Sell
Is VanEck Rare Earth & Strat Mtls ETF a Buy, Sell or Hold?
- The current VanEck Rare Earth & Strat Mtls ETF [REMX] share price is $42.52. The Score for REMX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- REMX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $243.08. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
REMX Stock Price Chart
What is VanEck Rare Earth & Strat Mtls ETF's stock price today?
-
The VanEck Rare Earth & Strat Mtls ETF share price today is $42.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REMX is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $243.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
REMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.46 | Sell |
| Relative Strength Index (14 RSI): | 24.54 | Sell |
| Chaikin Money Flow: | -43388 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.17 - 51.51) | Sell |
| Bollinger Bands (100): | (47.35 - 53.79) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 22.91 | Buy |
| Relative Strength Index (14 RSI): | 86.77 | Buy |
| Chaikin Money Flow: | -1210062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (135.8 - 205.74) | Buy |
| Bollinger Bands (100): | (136.44 - 176.64) | Buy |
REMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.52 | Sell |
| 20-day SMA: | 46.63 | Sell |
| 50-day SMA: | 50.37 | Sell |
| 200-day SMA: | 54.57 | Sell |
| 8-day EMA: | 43.77 | Sell |
| 20-day EMA: | 46.19 | Sell |
| 50-day EMA: | 49.06 | Sell |
| 200-day EMA: | 56.31 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 209.44 | Buy |
| 20-day SMA: | 176.25 | Buy |
| 50-day SMA: | 159.62 | Buy |
| 200-day SMA: | 165.96 | Buy |
| 8-day EMA: | 218.01 | Buy |
| 20-day EMA: | 188.75 | Buy |
| 50-day EMA: | 168.9 | Buy |
| 200-day EMA: | 168.09 | Buy |
VanEck Rare Earth & Strat Mtls ETF Earnings Growth & REMX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
VanEck Rare Earth & Strat Mtls ETF Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||